Terms: = Lung cancer AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181
59 results:
1. Circular RNA circATP9A promotes non-small cell lung cancer progression by interacting with HuR and by promoting extracellular vesicles-mediated macrophage M2 polarization.
Yao Y; Chen C; Wang J; Xuan H; Chen X; Li Z; Yang F; Wang B; Lin S; Li S; Tang D; Gong L; Gao W
J Exp Clin Cancer Res; 2023 Dec; 42(1):330. PubMed ID: 38049814
[TBL] [Abstract] [Full Text] [Related]
2. Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC.
Wang K; Du R; Myall NJ; Lewis WE; Uy N; Hong L; Skoulidis F; Byers LA; Tsao A; Cascone T; Pozadzides J; Tu J; Negrao MV; Gibbons DL; Park K; Rinsurongkawong W; Lee JJ; Gandara D; Behl D; Shu CA; Riess JW; Baik C; Wakelee HA; Vaporciyan AA; Heymach JV; Zhang J; Le X
J Thorac Oncol; 2024 Mar; 19(3):500-506. PubMed ID: 38012986
[TBL] [Abstract] [Full Text] [Related]
3. SUMOylation-triggered ALIX activation modulates extracellular vesicles circTLCD4-RWDD3 to promote lymphatic metastasis of non-small cell lung cancer.
Diao X; Guo C; Zheng H; Zhao K; Luo Y; An M; Lin Y; Chen J; Li Y; Li Y; Gao X; Zhang J; Zhou M; Bai W; Liu L; Wang G; Zhang L; He X; Zhang R; Li Z; Chen C; Li S
Signal Transduct Target Ther; 2023 Nov; 8(1):426. PubMed ID: 37925421
[TBL] [Abstract] [Full Text] [Related]
4. The negative effect of concomitant medications on immunotherapy in non-small cell lung cancer: An umbrella review.
Chen J; Chen S; Luo H; Long S; Yang X; He W; Wu W; Wang S
Int Immunopharmacol; 2023 Nov; 124(Pt B):110919. PubMed ID: 37722262
[TBL] [Abstract] [Full Text] [Related]
5. RNA-binding protein-regulated fibronectin is essential for EGFR-activated metastasis of head and neck squamous cell carcinoma.
Shieh JM; Chang TW; Wang JH; Liang SP; Kao PL; Chen LY; Yen CJ; Chen YJ; Chang WC; Chen BK
FASEB J; 2023 Oct; 37(10):e23206. PubMed ID: 37718485
[TBL] [Abstract] [Full Text] [Related]
6. hnrnpa2b1-mediated m
Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L
J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993
[TBL] [Abstract] [Full Text] [Related]
7. LINC00963 promotes the malignancy and metastasis of lung adenocarcinoma by stabilizing Zeb1 and exosomes-induced M2 macrophage polarization.
Hu R; Xu B; Ma J; Li L; Zhang L; Wang L; Zhu J; Guo T; Zhang H; Wang S
Mol Med; 2023 Jan; 29(1):1. PubMed ID: 36604626
[TBL] [Abstract] [Full Text] [Related]
8. N6-methyladenosine in hematological malignancies: a concise review.
Wang WJ; Xu TT; Bao J
Curr Opin Hematol; 2023 Jan; 30(1):4-13. PubMed ID: 36165537
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Analysis of Gene Signatures of m6ARNA Methylation Regulators in lung Adenocarcinoma and Development of a Risk Scoring System.
Gao C; Li H; Ma W; Zhang Q; Liu C; Liu L; Zhuang J; Sun C
J Immunol Res; 2022; 2022():7519838. PubMed ID: 36061307
[TBL] [Abstract] [Full Text] [Related]
10. Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in lung Adenocarcinoma.
Wang N; Xu Y; Jin L; Wang X; Wu S; Wang Y; Zhao J; Zhou F; Ge H
Dis Markers; 2022; 2022():1829528. PubMed ID: 36051357
[TBL] [Abstract] [Full Text] [Related]
11. hnrnpa2b1 Demonstrates Diagnostic and Prognostic Values Based on Pan-cancer Analyses.
Chen C; Huang L; Sun Q; Yu Z; Wang X; Bu L
Comput Math Methods Med; 2022; 2022():9867660. PubMed ID: 35529270
[TBL] [Abstract] [Full Text] [Related]
12. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
Li D; Fu Z; Dong C; Song Y
Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
[TBL] [Abstract] [Full Text] [Related]
13. A Study on microRNAs Targeting the Genes Overexpressed in lung cancer and their Codon Usage Patterns.
Chakraborty S; Nath D
Mol Biotechnol; 2022 Oct; 64(10):1095-1119. PubMed ID: 35435592
[TBL] [Abstract] [Full Text] [Related]
14. hnrnpa2b1 inhibited SFRP2 and activated Wnt-β/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.
Rong L; Xu Y; Zhang K; Jin L; Liu X
Pathol Res Pract; 2022 May; 233():153794. PubMed ID: 35364458
[TBL] [Abstract] [Full Text] [Related]
15. Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in lung Adenocarcinoma.
Wang Y; Zhao X; Li J; Wang X; Hu W; Zhang X
Technol Cancer Res Treat; 2022; 21():15330338221085373. PubMed ID: 35343834
[No Abstract] [Full Text] [Related]
16. Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial.
Blayney DW; Mohanlal R; Adamchuk H; Kirtbaya DV; Chen M; Du L; Ogenstad S; Ginn G; Huang L; Zhang Q
JAMA Netw Open; 2022 Jan; 5(1):e2145446. PubMed ID: 35084480
[TBL] [Abstract] [Full Text] [Related]
17. hnrnpa2b1-Mediated Extracellular Vesicles Sorting of miR-122-5p Potentially Promotes lung cancer Progression.
Li C; Qin F; Wang W; Ni Y; Gao M; Guo M; Sun G
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884671
[TBL] [Abstract] [Full Text] [Related]
18. Expression and prognostic significance of m6A-related genes in TP53-mutant non-small-cell lung cancer.
Zhao Z; Wan J; Guo M; Wang Y; Yang Z; Zhou F; Li Z; Ming L
J Clin Lab Anal; 2022 Jan; 36(1):e24118. PubMed ID: 34812534
[TBL] [Abstract] [Full Text] [Related]
19. The RNA N
Jin L; Chen C; Yao J; Yu Z; Bu L
Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):329-340. PubMed ID: 34717005
[TBL] [Abstract] [Full Text] [Related]
20. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non‑small cell lung cancer cells.
Kim MK; Choi MJ; Lee HM; Choi HS; Park YK; Ryu CJ
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109989
[TBL] [Abstract] [Full Text] [Related]
[Next]